Vimarsana
Biggest News Aggregation in the World

Page 2 - Mathilde Bohin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mathilde Bohin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mathilde Bohin Today - Breaking & Trending Today

GeNeuro: Monthly Statement of Total Voting Rights and Shares Forming the Company's Share Capital - Vimarsana News

GeNeuro: Monthly Statement of Total Voting Rights and Shares Forming the Company's Share Capital

Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: GeNeuro (Paris:GNRO): Market: Euronext Paris ISIN code Mnemo: CH0308403085 GNRO Web

IMPLANET Signs an Exclusive Distribution Contract for SMTP Technology Co.'s Ultrasonic Surgical Scalpel in France - Vimarsana News

IMPLANET Signs an Exclusive Distribution Contract for SMTP Technology Co.'s Ultrasonic Surgical Scalpel in France

SMTP Technology Co., a Sanyou Medical subsidiary, is a Chinese company specialized in manufacturing and marketing ultrasonic medical equipment Exclusive distribution agreement covering healthcare

IMPLANET Announces 9-month Revenue of €6 Million as of September 30, 2022, up +37% - Vimarsana News

IMPLANET Announces 9-month Revenue of €6 Million as of September 30, 2022, up +37%

Revenue increase driven by business in France and the rest of the world, which grew by 40% and 73% respectively Third consecutive quarter of revenue growth Success of the proposed capital

The Karolinska Institutet's Academic Specialist Center (ASC) to Present Results of GeNeuro's ProTEct-MS Phase 2 Study of Temelimab at ECTRIMS 2022 - Vimarsana News

The Karolinska Institutet's Academic Specialist Center (ASC) to Present Results of GeNeuro's ProTEct-MS Phase 2 Study of Temelimab at ECTRIMS 2022

Regulatory News: GeNeuro (Euronext Paris: CH0308403085 GNRO), a biopharmaceutical company focused on stopping causal factors driving the progression of neurodegenerative and autoimmune diseases such

Implanet announces the success of its capital increase - Vimarsana News

Implanet announces the success of its capital increase

First fundraising of €2.77 million through the issuance of 9,879,254 shares with warrants Acquisition of a 28.96% stake in Sanyou (HK) International Medical Holding Co. limited ("Sanyou Medical")